Next Article in Journal
The Notable Role of Telomere Length Maintenance in Complex Diseases
Previous Article in Journal
Correction: Chen et al. Heteronemin Suppresses Lymphangiogenesis Through ARF-1 and MMP-9/VE-Cadherin/Vimentin. Biomedicines 2021, 9, 1109
Previous Article in Special Issue
Regenerative Medicine in Diabetes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Sharma et al. Modulation of Renal Injury by Variable Expression of Myo-Inositol Oxygenase (MIOX) via Perturbation in Metabolic Sensors. Biomedicines 2020, 8, 217

Department of Pathology, Northwestern University, Chicago, IL 60611, USA
*
Author to whom correspondence should be addressed.
Biomedicines 2024, 12(11), 2610; https://doi.org/10.3390/biomedicines12112610
Submission received: 22 November 2023 / Accepted: 31 October 2024 / Published: 15 November 2024
(This article belongs to the Special Issue Regenerative Medicine in Diabetes)
In the original publication [1], there was a mistake in Figure 3 in the published version. Figure 3G got duplicated while assembling Figure 3. The corrected Figure 3 is shown below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Sharma, I.; Deng, F.; Kanwar, Y.S. Modulation of Renal Injury by Variable Expression of Myo-Inositol Oxygenase (MIOX) via Perturbation in Metabolic Sensors. Biomedicines 2020, 8, 217. [Google Scholar] [CrossRef] [PubMed]
Figure 3. Modulation of expression of sirtuins and transcription factors (PGC-1α and YY-1) by MIOX. Panels (A,B): immunoblotting data indicated a decreased expression of Sirt1, Sirt3 and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and Ying-Yang1 (YY-1) following HFD administration in various strains of mice. The most notable reduction was seen in MIOX-TG mice prior to and following HFD treatment. The ob/ob mice also had reduced expression, and it was considerably restored in ob/MIOXKO mice. Panels (CH): immunofluorescence microscopy revealed reduced expression of YY-1 in HK-2 cells (proximal tubular cell line) transfected with MIOX pcDNA, which was further decreased following treatment with palmitate-BSA (P-BSA). The exposure of MIOX-siRNA to P-BSA-treated HK-2 cells partially restored the expression of YY-1 (magnification: 200×). Panel (I): Western blot data indicated the changes in the expression of MIOX and Sirt1, which basically recapitulated the changes observed in YY-1 transcription factor in HK-2 cells after various treatments.
Figure 3. Modulation of expression of sirtuins and transcription factors (PGC-1α and YY-1) by MIOX. Panels (A,B): immunoblotting data indicated a decreased expression of Sirt1, Sirt3 and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and Ying-Yang1 (YY-1) following HFD administration in various strains of mice. The most notable reduction was seen in MIOX-TG mice prior to and following HFD treatment. The ob/ob mice also had reduced expression, and it was considerably restored in ob/MIOXKO mice. Panels (CH): immunofluorescence microscopy revealed reduced expression of YY-1 in HK-2 cells (proximal tubular cell line) transfected with MIOX pcDNA, which was further decreased following treatment with palmitate-BSA (P-BSA). The exposure of MIOX-siRNA to P-BSA-treated HK-2 cells partially restored the expression of YY-1 (magnification: 200×). Panel (I): Western blot data indicated the changes in the expression of MIOX and Sirt1, which basically recapitulated the changes observed in YY-1 transcription factor in HK-2 cells after various treatments.
Biomedicines 12 02610 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sharma, I.; Deng, F.; Kanwar, Y.S. Correction: Sharma et al. Modulation of Renal Injury by Variable Expression of Myo-Inositol Oxygenase (MIOX) via Perturbation in Metabolic Sensors. Biomedicines 2020, 8, 217. Biomedicines 2024, 12, 2610. https://doi.org/10.3390/biomedicines12112610

AMA Style

Sharma I, Deng F, Kanwar YS. Correction: Sharma et al. Modulation of Renal Injury by Variable Expression of Myo-Inositol Oxygenase (MIOX) via Perturbation in Metabolic Sensors. Biomedicines 2020, 8, 217. Biomedicines. 2024; 12(11):2610. https://doi.org/10.3390/biomedicines12112610

Chicago/Turabian Style

Sharma, Isha, Fei Deng, and Yashpal S. Kanwar. 2024. "Correction: Sharma et al. Modulation of Renal Injury by Variable Expression of Myo-Inositol Oxygenase (MIOX) via Perturbation in Metabolic Sensors. Biomedicines 2020, 8, 217" Biomedicines 12, no. 11: 2610. https://doi.org/10.3390/biomedicines12112610

APA Style

Sharma, I., Deng, F., & Kanwar, Y. S. (2024). Correction: Sharma et al. Modulation of Renal Injury by Variable Expression of Myo-Inositol Oxygenase (MIOX) via Perturbation in Metabolic Sensors. Biomedicines 2020, 8, 217. Biomedicines, 12(11), 2610. https://doi.org/10.3390/biomedicines12112610

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop